Astellas Pharma to acquire Iveric Bio in $5.9 billion deal
Japanese pharmaceutical company Astellas Pharma has agreed to buy US company Iveric Bio for about $5.9 billion, representing $40 per share in cash.
The purchase price...
Mon, 01/05/2023 - 06:09